Evidence map›Paper›PMID 25225100›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2014

GABA(B) receptor-mediated activation of astrocytes by gamma-hydroxybutyric acid.

Timothy Gould, Lixin Chen, Zsuzsa Emri, Tiina Pirttimaki, Adam C Errington, Vincenzo Crunelli, H Rheinallt Parri

Open access · hybridAbstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  3. GABA-independent activation of GABANature communications · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Astrocytic Calcium and cAMP in Neurodegenerative Diseases.Frontiers in cellular neuroscience · 2022
    Review
  8. A requirement for astrocyte IPFrontiers in cellular neuroscience · 2022
    Article
  9. Astrocytes: GABAceptive and GABAergic Cells in the Brain.Frontiers in cellular neuroscience · 2022
    Review
  10. Astrocyte-neuron signaling in the mesolimbic dopamine system: the hidden stars of dopamine signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. The Paradox of Astroglial CaFrontiers in cellular neuroscience · 2020
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Timothy GouldNeuroscience Division, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK.
Lixin ChenNeuroscience Division, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK.
Zsuzsa EmriNeuroscience Division, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK.
Tiina PirttimakiSchool of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK.
Adam C ErringtonNeuroscience Division, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK.
Vincenzo CrunelliNeuroscience Division, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK crunelli@cardiff.ac.uk.
H Rheinallt ParriSchool of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK parrihr@aston.ac.uk.
Cardiff University · GBAston University · GB

Funding

Medical Research Council G0900671Wellcome Trust 091882
6 · The paper itself

Abstract

The gamma-aminobutyric acid (GABA) metabolite gamma-hydroxybutyric acid (GHB) shows a variety of behavioural effects when administered to animals and humans, including reward/addiction properties and absence seizures. At the cellular level, these actions of GHB are mediated by activation of neuronal GABA(B) receptors (GABA(B)Rs) where it acts as a weak agonist. Because astrocytes respond to endogenous and exogenously applied GABA by activation of both GABA(A) and GABA(B)Rs, here we investigated the action of GHB on astrocytes on the ventral tegmental area (VTA) and the ventrobasal (VB) thalamic nucleus, two brain areas involved in the reward and proepileptic action of GHB, respectively, and compared it with that of the potent GABA(B)R agonist baclofen. We found that GHB and baclofen elicited dose-dependent (ED50: 1.6 mM and 1.3 µM, respectively) transient increases in intracellular Ca(2+) in VTA and VB astrocytes of young mice and rats, which were accounted for by activation of their GABA(B)Rs and mediated by Ca(2+) release from intracellular store release. In contrast, prolonged GHB and baclofen exposure caused a reduction in spontaneous astrocyte activity and glutamate release from VTA astrocytes. These findings have key (patho)physiological implications for our understanding of the addictive and proepileptic actions of GHB.

Indexed as

AnimalsAstrocytesBaclofenDose-Response Relationship, DrugEpilepsyFemaleHydroxybutyratesMaleMiceMice, KnockoutMicroscopy, FluorescenceRatsRats, WistarReceptors, GABA-BRewardVentral Tegmental Area4-hydroxybutyric acidBaclofenHydroxybutyratesReceptors, GABA-Babsence seizuresbaclofenrewardthalamusventral tegmental area

Identifiers

PMID25225100
PMCPMC4173292
OpenAlexW2104067551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.